|
Fund Overview
Quote
Performance
|
Chart
Charting
Compare to:
|
Top News
More News
Notable ETF Outflow Detected - IHE, AGN, ELAN, MYL
July 16, 2019
Symbols mentioned in this story: IHE, AGN, ELAN, MYL Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... Read More
from ETF Channel
Analysts Anticipate 22% Gains Ahead For IHE
July 15, 2019
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... Read More
from ETF Channel
4 Hot Pharmaceutical ETFs
July 14, 2019
Pharmaceutical ETFs invest in stocks of companies that are involved in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. With Johnson and Johnson... Read More
from ETF Trends
Since 1887, Johnson & Johnson has been a staple in the healthcare industry, with a plethora of household name products under its umbrella, including Listerine, Sudafed, and Benadryl. Recently however,... Read More
from ETF Trends
Add Up The Parts: IHE Could Be Worth $180
June 27, 2019
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... Read More
from ETF Channel
Pharmaceutical sector-specific exchange traded funds showed mixed results Tuesday after AbbVie (NYSE: ABBV) agreed to acquire Allergan (NYSE: AGN) for $63 billion. Among the largest pharma-specific... Read More
from ETF Trends
IHE's Holdings Imply 25% Gain Potential
June 17, 2019
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... Read More
from ETF Channel
Legal Troubles Beset Pharmaceutical Sector ETFs
May 14, 2019
Pharmaceutical ETFs may be in trouble with legal troubles looming over the industry. The drugmaker segment recently sold-off after an amended civil antitrust complaint brought by more than 40 state... Read More
from ETF Trends
Pharmaceutical ETFs Catch Healthcare Contagion
April 18, 2019
The retreat in healthcare stocks is bleeding over, with areas like pharmaceutical sector exchange traded funds being dragged down by association. The iShares U.S. Pharmaceuticals ETF (NYSEArca: IHE)... Read More
from ETF Trends
Tom Lydon on CNBC: Can Health Care Cure Itself?
April 15, 2019
Uncertainty and skepticism are a cause of sickness in the tried-and-true health care sector, which has been the worst performer in the S&P 500 in 2019–up a paltry 3.8 percent compared to the broader... Read More
from ETF Trends
We Did The Math IHE Can Go To $182
April 11, 2019
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... Read More
from ETF Channel
4 ETFs to Consider with Big Pharma on Senate’s Hot Seat
April 09, 2019
Big pharmaceutical companies were on the hot seat at Capital Hill today with CVS Health , Cigna , Prime Therapeutics, Humana, and UnitedHealthcare’s OptumRx testifying before the Senate Finance... Read More
from ETFdb
4 ETFs to Consider with Big Pharma on the Senate’s Hot Seat
April 09, 2019
Big pharmaceutical companies were on the hot seat at Capitol Hill today with CVS Health, Cigna, Prime Therapeutics, Humana, and UnitedHealthcare’s OptumRx testifying before the Senate Finance Committee... Read More
from ETF Trends
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.